November 8, 2017 7:35am
The period before and during quarterly releases
… Is like crawling through the mud; slow, slushy and slippery
There is an under supply of reliable information about the sector …
No subscription - you’re missing situational awareness and the most trustworthy source of independent insight!
Pre-open trading indications: 7 SELLs and 1 BUY
Quarterly financial results: AYHX, ADVM, CAPR and RGNX
For continued access to what one industry CEO calls the “bible” for smart investing in the RegMed, gene and cell therapy sector’ … I’d recommend being a subscriber!
Is the truth so hard to fathom?
Members only. Please login.